Insider trades

Yeleswaram Krishnaswamy

Yeleswaram Krishnaswamy made 0 buys and 9 sales on the open market in the last 12 months at Rapport Therapeutics, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Aug 25, 2026Rapport Therapeutics, Inc.Sale16,201US$51
Aug 25, 2026Rapport Therapeutics, Inc.Sale20,799US$50
Aug 24, 2026Rapport Therapeutics, Inc.Sale13,160US$50
Aug 19, 2026Rapport Therapeutics, Inc.Sale404US$50
Apr 17, 2026Rapport Therapeutics, Inc.Sale20,225US$40
Apr 14, 2026Rapport Therapeutics, Inc.Sale10,200US$35
Apr 13, 2026Rapport Therapeutics, Inc.Sale9,165US$35
Apr 10, 2026Rapport Therapeutics, Inc.Sale500US$35
Apr 8, 2026Rapport Therapeutics, Inc.Sale360US$35